Rita Nanda to Drug Resistance, Neoplasm
This is a "connection" page, showing publications Rita Nanda has written about Drug Resistance, Neoplasm.
Connection Strength
0.058
-
Targeting the human epidermal growth factor receptor 2 (HER2) in the treatment of breast cancer: recent advances and future directions. Rev Recent Clin Trials. 2007 May; 2(2):111-6.
Score: 0.058